PBRM1 and nonpapillary renal cell carcinoma: Regarding chromatin remodeling enzymes, ccRCC commonly harbor BAP1 and PBRM1 inactivating mutations (mutated in approximately 15% and 50% of ccRCC cases, respectively) [98].